πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11555021

Fatty acid derivatives and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11547736

Sauvignon blanc grape seed products for nonalcoholic fatty liver disease

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11549125

Closed-ended, linear, duplex adenoassociated virus DNA, and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11542261

Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors

The United States of America as Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11542320

Nucleic acids encoding single domain antibodies to chikungunya virus

The Government of the United States of America, as represented by the Secretary of the Navy Β· Granted Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11535870

Adeno-associated virus vectors encoding modified G6PC and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11535651

Hepatitis B nanoparticle-based vaccine for influenza virus

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11530424

Efficient CRISPR/HDR-mediated knock-in system and method of use

United States Department of Veteran Affairs Β· Granted Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11529312

Francisella lipids as broad anti-inflammatory therapeutics and associated methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11524051

Methods of treating fungal infections

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11524017

Method of using substrates of AKR1B1/AKR1B10 as anti-cancer drugs

Beijing Normal University Hong Kong Baptist University United International College Β· Granted Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11523613

Ferrate compositions for surface disinfection

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11512313

Functionally-interdependent shape switching nucleic acid nanoparticles

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11510998

Gene therapy for combined methylmalonic acidemia/aciduria and hyperhomocysteinemia/homocys

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11512052

Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11510887

Sobetirome in the treatment of myelination diseases

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11498942

Antigenic tripeptides derived from Mycobacterium avium subsp. paratuberculosis s-type stra

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11497739

Materials and methods for diagnosis, prevention and/or treatment of stress disorders and c

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11497803

Modulation of replicative fitness by deoptimization of synonymous codons

THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION Β· Granted Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11491187

Methods of conditioning patients for T cell therapy

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11491123

Pharmaceutical compositions with antiflaviviral activity

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11484511

Pharmaceutical composition comprising THA as effective ingredient for treatment of prostat

KOREA UNITED PHARM. INC. Β· Granted Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11485709

Cannabinoid receptor mediating compounds

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11478542

Immunogenic RSV polypeptides

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted